# FDA 483 - Ducommun Labarge Technologies - June 27, 2025

Source: https://www.keypedia.com/records/483/ducommun-labarge-technologies/c2b55c9e-6a35-428a-b61c-8df3af0a8b56

> FDA 483 for Ducommun Labarge Technologies on June 27, 2025. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ducommun Labarge Technologies
- Inspection Date: 2025-06-27
- Product Type: device
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Ducommun Labarge Technologies in Appleton, WI, revealed significant deficiencies in their quality system for medical device manufacturing. The firm failed to adequately establish procedures for corrective and preventive actions, lacked proper validation for a critical manufacturing process, and did not ensure adequate acceptance activities for incoming materials. These issues indicate a need for improved quality control and adherence to regulatory requirements.

## Related Officers

- [Shuana H. Xiong](https://www.keypedia.com/people/shuana-h-xiong/45ee2b1d-fbb8-452e-a218-8d79e8425fc8)

Company: https://www.keypedia.com/companies/ducommun-labarge-technologies/9f552cb3-d285-4b49-a1ee-d9adbd6ba6d7

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
